Načítá se...
Severe carvedilol toxicity without overdose – caution in cirrhosis
BACKGROUND: Carvedilol is used in the management of hypertension, ischemic heart disease, heart failure and most recently, portal hypertension. It has been associated with improved outcomes regarding variceal bleeding, hepatic decompensation and death when compared to propranolol and endoscopic band...
Uloženo v:
| Vydáno v: | Clin Hypertens |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5709975/ https://ncbi.nlm.nih.gov/pubmed/29214053 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40885-017-0083-z |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|